STAT June 15, 2024
Patrick Skerrett

First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.

To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them. You can submit a Letter to the Editor here, or find the submission form at the end of any First Opinion essay.

“Curing rare childhood diseases will falter unless Congress steps up,” by Joe and Courtney Dion

My heart breaks for the Dion family who desperately deserve hope for a cure to the ultra-rare disease that afflicts their children, Peter and Maggie. Sadly, they are not alone:...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Related Articles:
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article